Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 5,571 |
| Receivables | 0 | 0 | 0 | 440 |
| Other current assets | 0 | 0 | 0 | 95 |
| TOTAL | $0 | $0 | $0 | $6,106 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 537 |
| Investments And Advances | 0 | 0 | 0 | 999 |
| TOTAL | $N/A | $N/A | $N/A | $1,536 |
| Total Assets | $0 | $0 | $0 | $11,886 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 11,239 |
| Accrued Expenses | 0 | 0 | 0 | 2,661 |
| Other current liabilities | 0 | 0 | 0 | 5,794 |
| TOTAL | $0 | $0 | $0 | $26,575 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $30,472 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 0 | 148 |
| Retained earnings | 0 | 0 | 0 | -80,455 |
| Other shareholders' equity | 0 | 0 | 0 | 190 |
| TOTAL | $0 | $0 | $0 | $-18,586 |
| Total Liabilities And Equity | $0 | $0 | $0 | $11,886 |